Dick J. Richel

Amsterdam University Medical Centers — Netherlands

Medicine · Health Sciences

47h-index17.5kcitations138works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(18), Pancreatic and Hepatic Oncology Research(16), Blood Coagulation and Thrombosis Mechanisms(13), Venous Thromboembolism Diagnosis and Management(12), Gastric Cancer Management and Outcomes(12)

Publications138 total

Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
Cancers·2021· 15 citedOpen Access
Phase I/II study of LDE225 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer.
Journal of Clinical Oncology·2021· 4 cited
Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-Analysis
CardioVascular and Interventional Radiology·2018· 195 citedOpen Access
A phase Ib study of everolimus combined with metformin for patients with advanced cancer
Investigational New Drugs·2017· 17 citedOpen Access
Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice
Molecular Medicine·2017· 22 citedOpen Access
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
The Lancet Oncology·2015· 372 cited
Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer
Cancer Chemotherapy and Pharmacology·2015· 67 citedOpen Access
Preoperative Chemoradiation Therapy in Combination With Panitumumab for Patients With Resectable Esophageal Cancer: The PACT Study
International Journal of Radiation Oncology*Biology*Physics·2014· 25 cited
Preoperative chemoradiotherapy in locally advanced gastric cancer, a phase I/II feasibility and efficacy study
Radiotherapy and Oncology·2014· 47 cited
Protease‐activated receptor‐1 drives pancreatic cancer progression and chemoresistance
International Journal of Cancer·2014· 84 citedOpen Access
Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
Journal of Clinical Oncology·2014· 499 cited
Protease‐activated receptor‐2 induces migration of pancreatic cancer cells in an extracellular ATP‐dependent manner
Journal of Thrombosis and Haemostasis·2013· 36 cited
Tumour–stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies
Cancer Treatment Reviews·2013· 123 cited
Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70
Diseases of the Esophagus·2012· 12 citedOpen Access
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
New England Journal of Medicine·2012· 5.3k citedOpen Access
A phase I/II, non-randomized, feasibility/safety and efficacy study of the combination of everolimus, cetuximab and capecitabine in patients with advanced pancreatic cancer
Investigational New Drugs·2012· 35 citedOpen Access
Fusion of intestinal epithelial cells with bone marrow derived cells is dispensable for tissue homeostasis
Scientific Reports·2012· 18 citedOpen Access
The developing cancer stem-cell model: clinical challenges and opportunities
The Lancet Oncology·2012· 405 cited
Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients
European Urology·2012· 24 cited
6 Helpen keuzehulpen kiezen?
Bohn Stafleu van Loghum eBooks·2012
page 1 of 7Next →

Frequent Co-authors

Maikel P. Peppelenbosch(9), Jan Paul Medema(6), Henri H. Versteeg(6), Louis Vermeulen(5), Sjoerd Rodenhuis(5), C. Arnold Spek(5), Mark I. van Berge Henegouwen(4), Jurriaan B. Tuynman(4), Henk‐Jan Guchelaar(4), Carina L. Bos(4), Jan H.M. Schellens(4), Tatjana M.H. Niers(4), Sander H. Diks(4), Maarten C.C.M. Hulshof(3), Jannet C. Beukema(3), Felipe de Sousa e Melo(3), Clara Klerk(3), Martin H. Prins(3), Harry R. Büller(3), Johanna W. Wilmink(3)